Heading 4
Heading 4
Heading 4
Heading 4
Heading 4
Heading 4
Heading 4
Heading 4
Heading 4
Heading 4
Heading 4
Heading 4
Mabura 40 mg Pen
Manufacturer/Marketed By : Hetero Healthcare Ltd
$311.65 $246.49
Mabura 40 mg Pen is a versatile medication designed to alleviate the symptoms of various inflammatory conditions, including ankylosing spondylitis, rheumatoid arthritis, psoriasis, ulcerative colitis, and Crohn's disease. This disease-modifying...
Collapsible text is perfect for longer content like paragraphs and descriptions. It's a great way to give people more information while keeping your layout clean. Link your text to anything, including an external website or a different page. You can set your text box to expand and collapse when people click, so they can read more or less info.
Adalimumab 40 mg
Active Pharmaceutical Ingredient
Mabura 40 mg Pen
311,65 $US
246,49 $US
Mabura 40 mg Pen is a versatile medication designed to alleviate the symptoms of various inflammatory conditions, including ankylosing spondylitis, rheumatoid arthritis, psoriasis, ulcerative colitis, and Crohn's disease. This disease-modifying anti-rheumatic drug (DMARD) functions as a monoclonal antibody that specifically targets and inactivates tumor necrosis factor-alpha (TNFα), a key player in the inflammatory process. By diminishing the levels of TNFα, Mabura effectively reduces swelling, pain, and redness, leading to enhanced physical mobility and improved quality of life for patients. It is essential to note that Mabura may carry certain risks, such as increased susceptibility to infections and potential allergic reactions, which necessitate careful monitoring by healthcare professionals. Patients are advised to discuss their medical history and any ongoing medications with their doctor before starting this treatment. With its targeted action and proven efficacy, Mabura 40 mg Pen offers a promising option for individuals seeking relief from the debilitating effects of autoimmune and inflammatory diseases. Always adhere to prescribed dosages and follow up with healthcare providers to ensure optimal outcomes while using this therapy.
Active Pharmaceutical Ingredient
Uses
• Mabura 40 mg pen is commonly used to manage rheumatoid arthritis, a chronic inflammatory disorder that primarily affects joints. By targeting specific pathways in the immune system, Mabura 40 mg pen helps reduce inflammation and improve joint function. Patients often experience a decrease in pain and swelling, allowing for better mobility. This medication can be an essential part of a comprehensive treatment plan for those living with this condition.
• Another indication for Mabura 40 mg pen is ankylosing spondylitis, a form of arthritis that primarily affects the spine. This medication works by modulating the immune response, which can help alleviate the stiffness and discomfort associated with this condition. Patients using Mabura 40 mg pen may notice improved spinal flexibility and a reduction in overall symptoms. It is often prescribed to enhance the quality of life for individuals dealing with chronic back pain.
• Mabura 40 mg pen is also effective in treating inflammatory bowel diseases such as Crohn's disease and ulcerative colitis. These conditions cause chronic inflammation of the gastrointestinal tract, leading to various debilitating symptoms. The action of Mabura 40 mg pen helps to reduce this inflammation, allowing patients to experience fewer flare-ups and improved gut health. Many find that incorporating this medication into their regimen significantly enhances their daily functioning.
• For individuals with skin conditions such as plaque psoriasis and hidradenitis suppurativa, Mabura 40 mg pen can provide substantial relief. This medication targets the underlying immune mechanisms that contribute to skin inflammation and lesions. Patients often report a marked improvement in their skin appearance and a reduction in itching and discomfort. Mabura 40 mg pen plays a crucial role in managing these chronic dermatological issues effectively.
Benefits
Rheumatoid arthritis: Rheumatoid arthritis (RA) is a chronic autoimmune disease that primarily affects the joints. It causes inflammation, pain, stiffness, and swelling in the joints and can also affect other parts of the body, such as the skin, eyes, lungs, heart, and blood vessels. Mabura helps reduce inflammation and manage the symptoms of rheumatoid arthritis.
Ankylosing spondylitis: Ankylosing spondylitis (AS) is a chronic inflammatory disease that primarily affects the spine, causing pain, stiffness, and reduced mobility. It is a form of arthritis that mainly affects the joints between the vertebrae in the spine and the sacroiliac joints where the spine connects to the pelvis. Mabura Pen Injection works by targeting and inhibiting tumor necrosis factor (TNF), a protein involved in inflammation. By reducing the inflammation associated with ankylosing spondylitis, Mabura 40 mg Pen can help relieve pain, stiffness, and other symptoms of the condition.
Crohn's disease: Crohn's disease is a chronic inflammatory bowel disease (IBD) that primarily affects the gastrointestinal tract. It can cause inflammation and damage to any part of the digestive system, from the mouth to the anus. Symptoms of Crohn's disease can vary but commonly include abdominal pain, diarrhea, weight loss, fatigue, and loss of appetite. Mabura Adalimumab 40 mg works by targeting and inhibiting tumor necrosis factor (TNF), a protein involved in inflammation. By reducing inflammation in the gastrointestinal tract, Mabura 40 mg Pen can help manage the symptoms of Crohn's disease, including abdominal pain, diarrhea, and inflammation.
Ulcerative colitis: Ulcerative colitis is a chronic inflammatory bowel disease that primarily affects the colon and rectum. Mabura Pen Injection can help reduce inflammation in the gastrointestinal tract and manage the symptoms of ulcerative colitis.
Hidradenitis suppurativa: Hidradenitis suppurativa (HS) is a chronic inflammatory skin condition that affects the hair follicles in areas of the body with a high concentration of sweat glands, such as the armpits, groin, and buttocks. Mabura 40 mg works by targeting and inhibiting tumor necrosis factor (TNF), a protein involved in inflammation. By reducing inflammation, Mabura 40 mg Pen can help alleviate symptoms and prevent the progression of hidradenitis suppurativa.
Juvenile idiopathic arthritis: Juvenile idiopathic arthritis (JIA) is a type of arthritis that occurs in children under the age of 16 and persists for at least six weeks. It is characterized by joint inflammation, pain, stiffness, and swelling. Mabura Injection for Arthritis works by inhibiting tumor necrosis factor (TNF), a protein involved in inflammation. By reducing inflammation in the joints, adalimumab helps manage the symptoms of juvenile idiopathic arthritis, including pain, stiffness, and swelling.
Plaque psoriasis: Psoriasis is a condition where the skin cells in the body grow too quickly and form scales and dry patches. They can grow anywhere, but most appear on the scalp, elbows, knees, and lower back. Mabura Pen Injection reduces the scaly, itchy patches that may develop on the different parts of the body. It may take several months to become fully effective. You should avoid drinking alcohol while having this treatment and drink plenty of water to stay hydrated.
Psoriatic arthritis: Psoriatic arthritis is a type of inflammatory arthritis that occurs in some individuals with psoriasis, a chronic skin condition. It causes joint pain, swelling, and stiffness and can affect any joint in the body. Mabura 40 mg Pen works by inhibiting tumor necrosis factor (TNF), a protein involved in inflammation. By reducing inflammation in the joints, adalimumab can help manage the symptoms of psoriatic arthritis, including joint pain, stiffness, and swelling.
Uveitis: Uveitis refers to the inflammation of the uvea, which is the middle layer of the eye. It can affect various parts of the uvea, including the iris, ciliary body, and choroid. Mabura Injection for Arthritis is a tumor necrosis factor (TNF) inhibitor that helps reduce inflammation by targeting TNF, a protein involved in the immune response.
Side Effects
As with all medicines, Mabura Injection for Arthritis may cause side effects that do not require medical attention and that will disappear as your body adjusts to the medicine. If they persist or you're concerned about them, tell your doctor.
Most Common Side Effects
• Headache
• Rashes
• Sinusitis
• Nausea
• Fever
• Itching
• uneasiness
• Urinary tract infection
• Red scaly patches
• Tingling and Numbness
• Vision problems
• limb weakness
• Respiratory distress
• Chest pain hives
• sore throat
• Pale skin
• Dizziness
Common Side Effects
• Irregular heartbeats
• Heart failure (symptoms
• rapid breathing, pedal oedema, tachypnea)
• Muscle weakness
• Difficulty in movements like speaking, chewing, swallowing
• Vision changes
• Altered liver function, especially in those people who are exposed to Hepatitis B virus
How To Use
Mabura 40 mg Pen is given subcutaneously (under the skin) from any health care professional. Dosage and frequency will be decided by your doctor as per your disease condition and several other factors.
Safety Advice
• Alcohol: It is generally not recommended to drink alcohol while taking Mabura Adalimumab 40 mg. It may increase the risk of liver damage. it is best to avoid alcohol or limit your alcohol consumption while taking any medication.
• Kidney: Patients with kidney disease should closely monitor kidney function while taking Mabura 40 mg Pen and report any unusual symptoms or changes in kidney function to their physician. The dose of Mabura 40 mg should be used with caution in patients with kidney disease. It is important to adjust the dose in patients with kidney disease.
• Breastfeeding: Mabura 40 mg is probably safe to use during breastfeeding. Limited human data suggests that the drug does not represent any significant risk to the baby.
• Liver: Mabura should be used with caution in patients with liver disease. It is important that patients with liver disease closely monitor liver function while taking Mabura Injection for Arthritis and report any unusual symptoms or changes in liver function to their doctor. The dose of Mabura Adalimumab 40 mg may need to be adjusted in patients with liver disease.
• Pregnancy: Mabura Pen Injection is generally considered safe to use during pregnancy. Animal studies have shown low or no adverse effects on the developing baby; however, there are limited human studies.
• Driving: Mabura 40 mg Pen may cause dizziness, fatigue, and difficulty concentrating and coordinating, which may affect your ability to drive a vehicle safely. It is important to follow your doctor's instructions and take necessary precautions, such as avoiding driving a vehicle or operating heavy machinery if you suffer from the side effects of this Mabura Adalimumab 40 mg.
Disclaimer
Sidmex Inovia s'efforce de fournir des informations exactes et fiables. Cependant, l'ensemble du contenu de ce site web, y compris les descriptions et compositions des produits, est fourni à titre informatif uniquement et ne saurait se substituer à un avis, un diagnostic ou un traitement médical professionnel.
Il est conseillé aux utilisateurs de consulter un professionnel de santé qualifié avant toute décision médicale. Les informations fournies ne doivent pas être utilisées pour l'autodiagnostic ou l'automédication.
Tous les produits présentés sont exclusivement destinés aux professionnels (B2B) et aux demandes de renseignements en gros. Sidmex Inovia ne promeut pas la consommation directe par les particuliers et vise à soutenir, et non à remplacer, la relation entre le professionnel de santé et le patient.
Les noms de produits, marques et logos appartiennent à leurs propriétaires respectifs et leur utilisation n'implique aucune affiliation ni aucun parrainage. Sidmex Inovia décline toute responsabilité quant aux conséquences découlant de l'utilisation des informations fournies sur ce site web.